Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1665, 2008-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raltegravir sets new BENCHMRK in treatment-resistant HIV
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Access to resources
Recommend
TDF an alternative in first-line treatment of HIV infection
Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. :
Raltegravir sets a new benchmark in triple-class resistant HIV-1
Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. :
Treatment of HIV infection with raltegravir
By Chirch Lisa M Morrison Sidonie Steigbigel Roy T
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. :
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :